» Articles » PMID: 35338775

Platelets Accumulate in Lung Lesions of Tuberculosis Patients and Inhibit T-cell Responses and Mycobacterium Tuberculosis Replication in Macrophages

Abstract

Platelets regulate human inflammatory responses that lead to disease. However, the role of platelets in tuberculosis (TB) pathogenesis is still unclear. Here, we show that patients with active TB have a high number of platelets in peripheral blood and a low number of lymphocytes leading to a high platelets to lymphocytes ratio (PL ratio). Moreover, the serum concentration of different mediators promoting platelet differentiation or associated with platelet activation is increased in active TB. Immunohistochemistry analysis shows that platelets localise around the lung granuloma lesions in close contact with T lymphocytes and macrophages. Transcriptomic analysis of caseous tissue of human pulmonary TB granulomas, followed by Gene Ontology analysis, shows that 53 platelet activation-associated genes are highly expressed compared to the normal lung tissue. In vitro activated platelets (or their supernatants) inhibit BCG-induced T- lymphocyte proliferation and IFN-γ production. Likewise, platelets inhibit the growth of intracellular macrophages of Mycobacterium (M.) tuberculosis. Soluble factors released by activated platelets mediate both immunological and M. tuberculosis replication activities. Furthermore, proteomic and neutralisation studies (by mAbs) identify TGF-β and PF4 as the factors responsible for inhibiting T-cell response and enhancing the mycobactericidal activity of macrophages, respectively. Altogether these results highlight the importance of platelets in TB pathogenesis.

Citing Articles

Evaluation of platelet indices as markers of tuberculosis among children in India.

J N, Venkataraman A, Thiruvengadam K, B B, M K, S S ERJ Open Res. 2024; 10(1).

PMID: 38410718 PMC: 10895425. DOI: 10.1183/23120541.00734-2023.


Platelet-derived microparticles adoptively transfer integrin β3 to promote antitumor effect of tumor-infiltrating T cells.

Zhou M, Feng Y, Zhang X, Chen J, Yao N, Fu S Oncoimmunology. 2024; 13(1):2304963.

PMID: 38235317 PMC: 10793703. DOI: 10.1080/2162402X.2024.2304963.


Platelet, a key regulator of innate and adaptive immunity.

Yan C, Wu H, Fang X, He J, Zhu F Front Med (Lausanne). 2023; 10:1074878.

PMID: 36968817 PMC: 10038213. DOI: 10.3389/fmed.2023.1074878.


High levels of PF4, VEGF-A, and classical monocytes correlate with the platelets count and inflammation during active tuberculosis.

Urban-Solano A, Flores-Gonzalez J, Cruz-Lagunas A, Perez-Rubio G, Buendia-Roldan I, Ramon-Luing L Front Immunol. 2022; 13:1016472.

PMID: 36325331 PMC: 9618821. DOI: 10.3389/fimmu.2022.1016472.


Development of prognostic scoring system for predicting 1-year mortality among pulmonary tuberculosis patients in South India.

Krishnamoorthy Y, Ezhumalai K, Murali S, Rajaa S, Majella M, Sarkar S J Public Health (Oxf). 2022; 45(2):e184-e195.

PMID: 36038507 PMC: 10273380. DOI: 10.1093/pubmed/fdac087.

References
1.
Yun S, Sim E, Goh R, Park J, Han J . Platelet Activation: The Mechanisms and Potential Biomarkers. Biomed Res Int. 2016; 2016:9060143. PMC: 4925965. DOI: 10.1155/2016/9060143. View

2.
Griesshammer M, Bangerter M, Sauer T, Wennauer R, Bergmann L, Heimpel H . Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. J Intern Med. 1999; 245(3):295-300. DOI: 10.1046/j.1365-2796.1999.00452.x. View

3.
Phillips J, Chang C, Lanier L . Platelet-induced expression of Fc gamma RIII (CD16) on human monocytes. Eur J Immunol. 1991; 21(4):895-9. DOI: 10.1002/eji.1830210406. View

4.
Bao W, Bussel J, Heck S, He W, Karpoff M, Boulad N . Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents. Blood. 2010; 116(22):4639-45. PMC: 2996119. DOI: 10.1182/blood-2010-04-281717. View

5.
Rajan S, Espina B, Liebman H . Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura. Br J Haematol. 2005; 129(6):818-24. DOI: 10.1111/j.1365-2141.2005.05542.x. View